Par Pharmaceutical, Inc. v. TWi Pharmaceuticals, Inc.

Application Number	Patent Number	External Links
-	US9101540	Espacenet Google Patents
-	US9101549	Espacenet Google Patents

COMPLAINT filed with Jury Demand against TWi Pharmaceuticals USA, Inc., TWi Pharmaceuticals, Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-1768123.) - filed by Par Pharmaceutical, Inc., Alkermes Pharma Ireland Limited. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Civil Cover Sheet)(nmb) (Entered: 08/11/2015)

2015-08-11

1

View

Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (nmb) (Entered: 08/11/2015)

2015-08-11

1

View

Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: July 21, 2011. Date of Expiration of Patent: April 22, 2024. (nmb) (Entered: 08/11/2015)

2015-08-11

1

View

Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) US 9,101,540 B2; US 9,101,549 B2;. (nmb) (Entered: 08/11/2015)

2015-08-11

1

View

Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by Par Pharmaceutical, Inc.. (nmb) (Entered: 08/11/2015)

2015-08-11

1

View

Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent T. Rowe Price Associates, Inc., Corporate Parent FMR LLC, Corporate Parent Wellington Management Group, LLP for Alkermes Pharma Ireland Limited filed by Alkermes Pharma Ireland Limited. (nmb) (Entered: 08/11/2015)

2015-08-11

1

View

Summons Issued with Magistrate Consent Notice attached as to TWi Pharmaceuticals USA, Inc. on 8/11/2015; TWi Pharmaceuticals, Inc. on 8/11/2015. Requesting party or attorney should pick up issued summons at the Help Desk, Room 4209, or call 302-573-6170 and ask the Clerk to mail the summons to them. (nmb)

2015-08-11

1

No Actions

Summons Issued

2015-08-11

1

No Actions

Case Assigned/Reassigned

2015-08-12

1

No Actions

Case Assigned to Judge Sue L. Robinson. Please include the initials of the Judge (SLR) after the case number on all documents filed. (rjb)

2015-08-12

1

No Actions

WAIVER OF SERVICE returned executed by Par Pharmaceutical, Inc., Alkermes Pharma Ireland Limited: For TWi Pharmaceuticals, Inc. waiver sent on 9/1/2015, answer due 11/2/2015. (Pascale, Karen) (Entered: 09/02/2015)

2015-09-02

1

View

WAIVER OF SERVICE returned executed by Par Pharmaceutical, Inc., Alkermes Pharma Ireland Limited: For TWi Pharmaceuticals USA, Inc. waiver sent on 9/1/2015, answer due 11/2/2015. (Pascale, Karen) (Entered: 09/02/2015)

2015-09-02

1

View

MOTION for Pro Hac Vice Appearance of Attorney Kenneth G. Schuler, Marc N. Zubick, Terrence J. Connolly, Thomas J. Humphrey and Melissa Brand of Latham & Watkins LLP - filed by Par Pharmaceutical, Inc.. (Pascale, Karen) (Entered: 09/17/2015)

2015-09-17

1

View

SO ORDERED, re 9 MOTION for Pro Hac Vice Appearance of Attorney Kenneth G. Schuler, Marc N. Zubick, Terrence J. Connolly, Thomas J. Humphrey and Melissa Brand of Latham & Watkins LLP filed by Par Pharmaceutical, Inc. Signed by Judge Sue L. Robinson on 9/18/2015. (fms)

2015-09-18

1

No Actions

SO ORDERED

2015-09-18

1

No Actions

Pro Hac Vice Attorney Terrence J. Connolly, Thomas J Humphrey for Par Pharmaceutical, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (cna)

2015-09-22

1

No Actions

Add Attorneys - PHV only

2015-09-22

1

No Actions

STIPULATION Re: TWI's Responses to Complaints re (1 in 1:15-cv-00698-SLR) Complaint, (1 in 1:15-cv-00710-SLR) Complaint, (1 in 1:15-cv-00486-SLR) Complaint, by Par Pharmaceutical Inc., Par Pharmaceutical, Inc.. (Pascale, Karen) (Entered: 09/24/2015)

2015-09-24

1

View

SO ORDERED, re 10 Stipulation filed by Par Pharmaceutical, Inc., Par Pharmaceutical Inc., Set/Reset Answer Deadlines: All defendants 11/2/2015. Signed by Judge Sue L. Robinson on 9/25/2015. (fms)

2015-09-25

1

No Actions

~Util - Set/Reset Answer Deadline AND SO ORDERED

2015-09-25

1

No Actions

Amended Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Endo International PLC for Par Pharmaceutical, Inc. filed by Par Pharmaceutical, Inc.. (Pascale, Karen) (Entered: 10/19/2015)

2015-10-19

1

View

STIPULATION Re: Consolidation by Par Pharmaceutical Inc.. (Pascale, Karen) (Entered: 10/21/2015)

2015-10-21

1

View

Create Case Association - dkt in member case for Consol or MDL

2015-10-22

1

No Actions

SO ORDERED

2015-10-22

1

No Actions

SO ORDERED, re (12 in 1:15-cv-00698-SLR, 45 in 1:15-cv-00486-SLR, 12 in 1:15-cv-00710-SLR) Stipulation re: Consolidation filed by Par Pharmaceutical Inc. The First, Second, and Third Actions are hereby consolidated for all purposes including trial. ALL FUTURE FILINGS SHALL BE MADE IN LEAD CASE 15-486-SLR ONLY. Signed by Judge Sue L. Robinson on 10/22/2015. Associated Cases: 1:15-cv-00486-SLR, 1:15-cv-00698-SLR, 1:15-cv-00710-SLR(nmfn)

2015-10-22

1

No Actions

Case associated with lead case: Create association to 1:15-cv-00486-SLR. (nmfn)

2015-10-22

1

No Actions

ANSWER to 1 Complaint, with Jury Demand by TWi Pharmaceuticals USA, Inc., TWi Pharmaceuticals, Inc..(Gattuso, Dominick) (Entered: 11/02/2015)

2015-11-02

1

View

Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 9,101,540 B2; 9,101,549 B2. (nmfn) (Entered: 01/25/2016)

2016-01-25

1

View

Terminate Case - Civil

2016-01-25

1

No Actions

CASE CLOSED per the closing of Lead Case No. 15-486-SLR. (nmfn)

2016-01-25

1

No Actions

Overview

Parties

Defendant

TWi Pharmaceuticals USA, Inc. Follow

Represented By

TWi Pharmaceuticals, Inc. Follow

Represented By

Plaintiff

Alkermes Pharma Ireland Limited Follow

Represented By

Par Pharmaceutical, Inc. Follow

Represented By

Court & Judges

Patents Involved

Docket Entries

Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (nmb) (Entered: 08/11/2015)

Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: July 21, 2011. Date of Expiration of Patent: April 22, 2024. (nmb) (Entered: 08/11/2015)

Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) US 9,101,540 B2; US 9,101,549 B2;. (nmb) (Entered: 08/11/2015)

Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by Par Pharmaceutical, Inc.. (nmb) (Entered: 08/11/2015)

Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent T. Rowe Price Associates, Inc., Corporate Parent FMR LLC, Corporate Parent Wellington Management Group, LLP for Alkermes Pharma Ireland Limited filed by Alkermes Pharma Ireland Limited. (nmb) (Entered: 08/11/2015)

Summons Issued

Case Assigned/Reassigned

Case Assigned to Judge Sue L. Robinson. Please include the initials of the Judge (SLR) after the case number on all documents filed. (rjb)

WAIVER OF SERVICE returned executed by Par Pharmaceutical, Inc., Alkermes Pharma Ireland Limited: For TWi Pharmaceuticals, Inc. waiver sent on 9/1/2015, answer due 11/2/2015. (Pascale, Karen) (Entered: 09/02/2015)

WAIVER OF SERVICE returned executed by Par Pharmaceutical, Inc., Alkermes Pharma Ireland Limited: For TWi Pharmaceuticals USA, Inc. waiver sent on 9/1/2015, answer due 11/2/2015. (Pascale, Karen) (Entered: 09/02/2015)

MOTION for Pro Hac Vice Appearance of Attorney Kenneth G. Schuler, Marc N. Zubick, Terrence J. Connolly, Thomas J. Humphrey and Melissa Brand of Latham & Watkins LLP - filed by Par Pharmaceutical, Inc.. (Pascale, Karen) (Entered: 09/17/2015)

SO ORDERED, re 9 MOTION for Pro Hac Vice Appearance of Attorney Kenneth G. Schuler, Marc N. Zubick, Terrence J. Connolly, Thomas J. Humphrey and Melissa Brand of Latham & Watkins LLP filed by Par Pharmaceutical, Inc. Signed by Judge Sue L. Robinson on 9/18/2015. (fms)

SO ORDERED

Pro Hac Vice Attorney Terrence J. Connolly, Thomas J Humphrey for Par Pharmaceutical, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (cna)

Add Attorneys - PHV only

STIPULATION Re: TWI's Responses to Complaints re (1 in 1:15-cv-00698-SLR) Complaint, (1 in 1:15-cv-00710-SLR) Complaint, (1 in 1:15-cv-00486-SLR) Complaint, by Par Pharmaceutical Inc., Par Pharmaceutical, Inc.. (Pascale, Karen) (Entered: 09/24/2015)

SO ORDERED, re 10 Stipulation filed by Par Pharmaceutical, Inc., Par Pharmaceutical Inc., Set/Reset Answer Deadlines: All defendants 11/2/2015. Signed by Judge Sue L. Robinson on 9/25/2015. (fms)

~Util - Set/Reset Answer Deadline AND SO ORDERED

Amended Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Endo International PLC for Par Pharmaceutical, Inc. filed by Par Pharmaceutical, Inc.. (Pascale, Karen) (Entered: 10/19/2015)

STIPULATION Re: Consolidation by Par Pharmaceutical Inc.. (Pascale, Karen) (Entered: 10/21/2015)

Create Case Association - dkt in member case for Consol or MDL

SO ORDERED

Case associated with lead case: Create association to 1:15-cv-00486-SLR. (nmfn)

ANSWER to 1 Complaint, with Jury Demand by TWi Pharmaceuticals USA, Inc., TWi Pharmaceuticals, Inc..(Gattuso, Dominick) (Entered: 11/02/2015)

Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 9,101,540 B2; 9,101,549 B2. (nmfn) (Entered: 01/25/2016)

Terminate Case - Civil

CASE CLOSED per the closing of Lead Case No. 15-486-SLR. (nmfn)

Track Case Updates

TWi Pharmaceuticals USA, Inc.

TWi Pharmaceuticals, Inc.

Alkermes Pharma Ireland Limited

Par Pharmaceutical, Inc.